| Literature DB >> 33042268 |
Kok Suen Cheng1, Rongbin Pan2, Huaping Pan2, Binglin Li2, Stephene Shadrack Meena2, Huan Xing2, Ying Jing Ng2, Kaili Qin2, Xuan Liao2, Benson Kiprono Kosgei2, Zhipeng Wang1, Ray P S Han1,2.
Abstract
A fully automated and accurate assay of rare cell phenotypes in densely-packed fluorescently-labeled liquid biopsy images remains elusive.Entities:
Keywords: ALICE; cell phenotyping software; circulating hybrid cells; hybrid artificial intelligence; image forgery detection
Mesh:
Substances:
Year: 2020 PMID: 33042268 PMCID: PMC7532685 DOI: 10.7150/thno.44053
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556
Baseline Patient Characteristics Stratified by CHC-T Positivity
| Patient characteristic | CHC-T negative (n=18) | CHC-T positive (n=14) | |
|---|---|---|---|
| Age, mean (SD) | 59.3 (7.8) | 58.6 (9.0) | 0.814 |
| Males, No. (%) | 6 (33) | 9 (64) | 0.082 |
| Albumin, mean (SD), g | 43.1 (3.3) | 41.6 (3.6) | 0.234 |
| CA19-9 serum, median (IQR), U/ml | 122 (28-174) | 104 (70.8-412) | 0.531 |
| CEA serum, median (IQR), U/ml | 2.4 (2.0-5.1) | 3.6 (2.2-8.4) | 0.368 |
| CA242 serum. Median (IQR), U/ml | 23.7 (5.7-70.5) | 39.2 (19.5-142.8) | 0.263 |
| Location of tumor: head/body or tail, No. (%) | 11 (61) / 7 (39) | 11 (79) / 3 (21) | 0.446 |
| Tumor size, median (IQR), No. (%) | 3.3 (2.0-4.8) | 3.0 (2.5-3.9) | 0.706 |
| 0.112 | |||
| T0 | 4 (22) | 1 (7) | |
| T1 | 4 (22) | 9 (64) | |
| T2 | 4 (22) | 2 (14) | |
| Tx | 6 (34) | 2 (14) | |
| 0.007 | |||
| N0 | 9 (50) | 2 (14) | |
| N1 | 3 (17) | 10 (72) | |
| Nx | 6 (33) | 2 (14) | |
| 0.412 | |||
| M0 | 12 (67) | 12 (86) | |
| M1 | 6 (33) | 2 (14) | |
| 0.275 | |||
| I | 1 (6) | 0 (0) | |
| II | 11 (61) | 12 (86) | |
| IV | 6 (33) | 2 (14) | |
| 0.448 | |||
| Well | 1 (6) | 0 (0) | |
| Moderate | 7 (39) | 7 (50) | |
| Poor | 4 (22) | 5 (36) | |
| Not specified | 6 (33) | 2 (14) | |
| 0.421 | |||
| No | 3 (17) | 4 (29) | |
| Yes | 9 (50) | 8 (57) | |
| Not specified | 6 (33) | 2 (14) | |
| 0.154 | |||
| No | 10 (56) | 12 (86) | |
| Yes | 2 (11) | 0 (0) | |
| Not specified | 6 (33) | 2 (14) | |
| 0.297 | |||
| No | 10 (56) | 8 (57) | |
| Yes | 2 (11) | 4 (29) | |
| Not specified | 6 (33) | 2 (14) | |
| 0.412 | |||
| Whipple | 8 (44) | 9 (64) | |
| Distal pancreatectomy | 4 (22) | 2 (14) | |
| Palliative surgery | 2 (11) | 1 (7) | |
| Others | 1 (6) | 2 (14) | |
| No surgery | 3 (17) | 0 (0) | |
| 0.333 | |||
| R0 | 5 (28) | 7 (50) | |
| R1/R2 | 7 (39) | 5 (36) | |
| Not specified | 6 (33) | 2 (14) | |
| 0.425 | |||
| No | 4 (22) | 3 (21) | |
| Yes | 12 (67) | 11 (79) | |
| Not specified | 2 (11) | 0 (0) | |
| Epithelial CTCs, mean (SD) | 8.3 (8.0) | 8.2 (6.7) | 0.965 |
| Mesenchymal CTCs, mean (SD) | 19.8 (13.5) | 17.2 (11.4) | 0.573 |
| Hybrid CTCs, mean (SD) | 14.1 (12.2) | 10.6 (7.5) | 0.349 |
| Total CTCs, mean (SD) | 42.2 (30.7) | 36.0 (24.1) | 0.538 |
Comparison of ALICE to other automated CTC detection software
| Software | Algorithm | Advantage | Disadvantage |
|---|---|---|---|
| Morphological operations based on cell area, length/width ratio and circularity at specific regions of the microfluidic chip | • Detection of fluorescently stained CTCs; | • Unable to detect H&E stained CTCs; | |
| Deep learning algorithm via an epithelial marker staining | • Detection of fluorescently stained CTCs; | • Unable to detect H&E stained CTCs; | |
| Morphological operations based on cell diameter and shape at 10 different focal lengths | Detection of H&E stained CTCs | • Unable to detect fluorescently stained CTCs; | |
| Hybrid AI that combines rule-based morphological operations and statistical machine learning algorithm | • Detection of fluorescently stained CTCs; | • Unable to detect H&E stained CTCs; |